Vidipha Central Pharmaceutical JSC (HOSE:VDP)

HOSE:VDP Income Statement

Financials in millions VND. Fiscal year is January - December.

Fiscal Year	FY 2023	FY 2022	FY 2008	FY 2007
Period Ending	Dec 31, 2023	Jan 1, 2023	Dec 31, 2008	Dec 31, 2007
Revenue	1,019,317	1,007,796	206,952	191,443
Revenue Growth (YoY)	1.14%	386.97%	8.10%	-
Cost of Revenue	748,737	755,408	163,049	148,668
Gross Profit	270,580	252,388	43,904	42,775
Selling, General & Admin	171,420	161,730	18,090	17,163
Operating Expenses	171,420	161,730	18,090	17,163
Operating Income	99,160	90,659	25,813	25,612
Interest Expense	-27,559	-20,546	-	-
Interest & Investment Income	17,176	7,895	4,815	3,000
Currency Exchange Gain (Loss)	1,905	-2,241	38.56	10.29
Other Non Operating Income (Expenses)	9,313	13,763	218.06	-10.63
EBT Excluding Unusual Items	99,996	89,530	30,885	28,612
Gain (Loss) on Sale of Investments	256.95	3,783	-367.05	-
Gain (Loss) on Sale of Assets	315.45	-	-	-
Pretax Income	100,569	93,314	30,518	28,612
Income Tax Expense	20,350	19,765	3,011	3,083
Net Income	80,219	73,548	27,507	25,529
Net Income to Common	80,219	73,548	27,507	25,529
Net Income Growth	9.07%	167.38%	7.75%	-
Shares Outstanding (Basic)	20	20	7	7
Shares Outstanding (Diluted)	20	20	7	7
Shares Change (YoY)	-	180.50%	9.02%	-
EPS (Basic)	3971.57	3641.32	3820.00	3865.00
EPS (Diluted)	3971.57	3641.32	3820.00	3865.00
EPS Growth	9.07%	-4.68%	-1.16%	-
Free Cash Flow	48,907	-53,901	24,811	21,031
Free Cash Flow Per Share	2421.35	-2668.58	3445.65	3184.01
Gross Margin	26.55%	25.04%	21.21%	22.34%
Operating Margin	9.73%	9.00%	12.47%	13.38%
Profit Margin	7.87%	7.30%	13.29%	13.33%
Free Cash Flow Margin	4.80%	-5.35%	11.99%	10.98%
EBITDA	126,500	111,456	31,480	32,582
EBITDA Margin	12.41%	11.06%	15.21%	17.02%
D&A For EBITDA	27,340	20,798	5,666	6,970
EBIT	99,160	90,659	25,813	25,612
EBIT Margin	9.73%	9.00%	12.47%	13.38%
Effective Tax Rate	20.23%	21.18%	9.87%	10.78%
Revenue as Reported	1,019,317	1,007,796	206,952	191,443

Source: S&P Global Market Intelligence. Standard template. Financial Sources.